Healthcare provider profile · identity verified

Meredith K Kelsen, NP

Nurse Practitioner · LISBON, ND · NPI 1417932823

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	583	123
Furosemide	Furosemide	478	68
Levothyroxine Sodium	Levothyroxine Sodium	393	79
Metoprolol Succinate	Metoprolol Succinate	393	77
Lisinopril	Lisinopril	371	83
Gabapentin	Gabapentin	332	46
Losartan Potassium	Losartan Potassium	325	81
Sertraline Hcl	Sertraline Hcl	312	61
Amlodipine Besylate	Amlodipine Besylate	288	61
Eliquis	Apixaban	267	40
Pantoprazole Sodium	Pantoprazole Sodium	236	37
Simvastatin	Simvastatin	236	60
Rosuvastatin Calcium	Rosuvastatin Calcium	227	65
Tamsulosin Hcl	Tamsulosin Hcl	216	41
Duloxetine Hcl	Duloxetine Hcl	201	29
Metoprolol Tartrate	Metoprolol Tartrate	187	41
Omeprazole	Omeprazole	186	55
Hydrochlorothiazide	Hydrochlorothiazide	171	45
Memantine Hcl	Memantine Hcl	141	18
Tramadol Hcl	Tramadol Hcl	132	27
Potassium Chloride	Potassium Chloride	125	22
Famotidine	Famotidine	124	36
Metformin Hcl Er	Metformin Hcl	123	35
Carvedilol	Carvedilol	120	19
Metformin Hcl	Metformin Hcl	117	31
Ozempic	Semaglutide	107	18
Prednisone	Prednisone	101	46
Alendronate Sodium	Alendronate Sodium	96	27
Buspirone Hcl	Buspirone Hcl	91	18
Klor-Con M20	Potassium Chloride	90	12
Venlafaxine Hcl Er	Venlafaxine Hcl	90	12
Clopidogrel	Clopidogrel Bisulfate	89	19
Alprazolam	Alprazolam	85	23
Meloxicam	Meloxicam	85	35
Quetiapine Fumarate	Quetiapine Fumarate	85	suppressed
Trazodone Hcl	Trazodone Hcl	85	25
Fluoxetine Hcl	Fluoxetine Hcl	84	17
Fluticasone Propionate	Fluticasone Propionate	84	28
Allopurinol	Allopurinol	82	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	73	18
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	73	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	72	51
Glipizide Er	Glipizide	72	13
Lorazepam	Lorazepam	69	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	15
Amoxicillin	Amoxicillin	63	50
Jantoven	Warfarin Sodium	63	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	60	suppressed
Montelukast Sodium	Montelukast Sodium	60	23
Oxybutynin Chloride Er	Oxybutynin Chloride	55	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	54	suppressed
Clonazepam	Clonazepam	53	suppressed
Mirtazapine	Mirtazapine	53	14
Tizanidine Hcl	Tizanidine Hcl	52	suppressed
Spironolactone	Spironolactone	50	suppressed
Oxycodone Hcl	Oxycodone Hcl	48	suppressed
Ondansetron Odt	Ondansetron	47	13
Tresiba Flextouch U-200	Insulin Degludec	47	suppressed
Bupropion Xl	Bupropion Hcl	46	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	11
Solifenacin Succinate	Solifenacin Succinate	45	15
Warfarin Sodium	Warfarin Sodium	45	11
Cephalexin	Cephalexin	44	23
Albuterol Sulfate Hfa	Albuterol Sulfate	43	19
Baclofen	Baclofen	42	suppressed
Bumetanide	Bumetanide	42	suppressed
Ezetimibe	Ezetimibe	42	15
Donepezil Hcl	Donepezil Hcl	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	14
Januvia	Sitagliptin Phosphate	39	suppressed
Carbamazepine	Carbamazepine	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Pregabalin	Pregabalin	37	11
Terazosin Hcl	Terazosin Hcl	36	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Atenolol	Atenolol	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Risedronate Sodium	Risedronate Sodium	35	12
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Budesonide	Budesonide	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Finasteride	Finasteride	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	22
Farxiga	Dapagliflozin Propanediol	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Fenofibrate	Fenofibrate,micronized	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Cefdinir	Cefdinir	25	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Nystatin	Nystatin	24	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Humulin N	Insulin Nph Human Isophane	22	suppressed
Lactulose	Lactulose	22	suppressed
Risperidone	Risperidone	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Novolog Flexpen	Insulin Aspart	21	suppressed
Temazepam	Temazepam	21	suppressed
Fluconazole	Fluconazole	20	15
Methylprednisolone	Methylprednisolone	20	18
Benazepril Hcl	Benazepril Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Topiramate	Topiramate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Metolazone	Metolazone	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Nitroglycerin	Nitroglycerin	16	14
Timolol Maleate	Timolol Maleate	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Digoxin	Digoxin	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error